ロード中...
Secondary prevention of recurrence by interferon therapy after ablation therapy for hepatocellular carcinoma in chronic hepatitis C patients
Chronic hepatitis C is a leading cause of hepatocellular carcinoma (HCC) worldwide. Interferon (IFN) therapy decreases the incidence of HCC in patients with chronic hepatitis C. Prevention of chronic-hepatitis-C-related HCC is one of the most important issues in current hepatology. We have previousl...
保存先:
| 第一著者: | |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
The WJG Press and Baishideng
2008
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2761574/ https://ncbi.nlm.nih.gov/pubmed/18985803 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.14.6140 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|